Trials / Completed
CompletedNCT02180230
Immediate Function of NobelSpeedy Shorty and Brånemark System® Mk III Shorty Implants in Daily Use
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Nobel Biocare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to evaluate the 7 mm long implants NobelSpeedy Shorty and Brånemark System Mk III Shorty: by determining the marginal bone remodeling, implant survival rate, soft tissue health and maintenance.
Detailed description
The primary endpoint was the change in marginal bone levels (in mm) from the time of implant insertion to follow-up visits (3, 6, 12, 36 and 60 months). Further endpoints were: * cumulative survival rates of the implants * soft tissue parameters (papilla index, bleeding on probing) * plaque formation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Shorty implants | Dental implant insertion to maxilla or mandible |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-07-02
- Last updated
- 2016-04-22
- Results posted
- 2016-04-22
Source: ClinicalTrials.gov record NCT02180230. Inclusion in this directory is not an endorsement.